We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new study, funded by Cancer Research UK (CRUK) and Wellcome, has discovered a new way to target the KRAS mutation, which is found in a number of hard-to-treat cancer types.
A survey has revealed that the majority of adults in the UK believe governments need to work together to develop COVID-19 vaccines and treatments, which if effective, should be used worldwide.
Wellcome has partnered with the Bill & Melinda Gates Foundation and Mastercard to provide up to $125m of seed funding to accelerate the development of Covid-19 therapies.
The Wellcome-funded Genomics of Drug Sensitivity in Cancer project has announced the publication of data from the past four years detailing the interaction between tumours and licensed and experimental drugs globally to support a genetic approach to futur